Press Releases

The 30th Ride for Roswell hits new fundraising record

BUFFALO, N.Y. — The 2025 Ride for Roswell hit an incredible milestone: 30 years supporting Roswell Park Comprehensive Cancer Center.

Saturday, June 28, 2025 - 03:00 pm

News

Dr. Renier Brentjens Recognized by Two Prominent Cancer Research Organizations

Roswell Park cellular therapy pioneer invited to address Damon Runyon Foundation, New York Academy of Sciences

Thursday, June 26, 2025 - 08:00 am

News

Roswell Park’s Dr. Sai Yendamuri Elected to the American Surgical Association

Cancer center's Chief Strategy Officer and Chair of Thoracic Surgery joins prestigious organization

Tuesday, June 17, 2025 - 09:00 am

Roswell Park hospital as seen from inside Kaminski Park

News

Newsweek Names Roswell Park to America's Best Cancer Hospitals List

Roswell Park Comprehensive Cancer Center has once again been named to Newsweek’s list of America’s Best Cancer Hospitals for 2025. Roswell Park has made the list every year since its inception in 2023.

Friday, June 6, 2025 - 01:00 pm

doctor in a lab coat stands in a laboratory

News

Study Featured at ASCO 2025 Highlights Potential New Treatment for Aggressive Form of Acute Myeloid Leukemia

An international clinical trial co-led by Roswell Park's Dr. Eunice Wang has demonstrated that the investigational drug ziftomenib can produce deep, durable responses in people with a specific biological subtype of acute myeloid leukemia (AML). Dr. Wang will present study findings at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Friday, May 30, 2025 - 12:00 pm

News

Roswell Park Quick Talks: Breast Cancer and ADCs, Risk of Second HPV-Related Cancer, Cognitive Function and ICIs

In talks at the annual meeting of the American Society of Clinical Oncology, experts from Roswell Park will give remarks on racial and ethnic disparities in outcomes among people with metastatic breast cancer; risk patterns for second cancers associated with human papillomavirus (HPV); and effects of immune checkpoint inhibitors (ICI) on cognitive function.

Thursday, May 29, 2025 - 09:00 am

News

Immune Checkpoint Inhibitors ‘High-Risk Yet Promising’ for Cancer Patients Who Undergo Organ Transplant

A meta-analysis led by Roswell Park's Muhammad Awidi, MD, has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhibitors before or after a solid-organ transplant. The study will be featured as an oral abstract during at the American Society of Clinical Oncology Annual Meeting in Chicago.

Wednesday, May 28, 2025 - 09:00 am

News

ASCO 2025 Highlights: Menin Inhibitor for Acute Myeloid Leukemia; Organ Transplant and Checkpoint Inhibitors

BUFFALO, N.Y. — Faculty from Roswell Park Comprehensive Cancer Center are among the international experts invited to share their research findings at the American Society of Clinical Oncology (ASCO) annual meeting May 30-June 3 at McCormick Place in Chicago.

Friday, May 23, 2025 - 10:00 am

News

Duration of Overweight/Obesity During Treatment Linked to Worse Outcomes in Pediatric Leukemia Patients

New research on children diagnosed with acute lymphoblastic leukemia shows that the longer a patient’s BMI falls within the overweight/obese category during treatment, the greater the risk of relapse and the lower the chance of survival.

Wednesday, May 14, 2025 - 11:00 am